Nubeqa (darolutamide) — Medica
Prostate cancer – metastatic, castration-sensitive
Initial criteria
- age ≥ 18 years
- used concurrently with a gonadotropin-releasing hormone (GnRH) analog OR patient has had a bilateral orchiectomy
Approval duration
1 year